Hallucinations and Development of Dementia in Parkinson's Disease.

Neuropsychiatric symptoms are common in Parkinson's disease (PD). We investigated the relationship between neuropsychiatric symptoms and current and future diagnosis of PD dementia (PDD). Individuals with PD who had a study partner were enrolled (n = 696). Study partners were administered the Neuropsychiatric Inventory or Neuropsychiatric Inventory Questionnaire at baseline. Participants were assigned a cognitive diagnosis at baseline and follow up visits. Hallucinations were significantly associated with a diagnosis of PDD cross-sectionally (p < 0.001) and with shortened time to dementia longitudinally among initially nondemented participants (n = 444; p = 0.005). Screening for hallucinations may be useful for assessing risk of dementia in participants with PD.

[1]  C. Ballard,et al.  Executive function but not episodic memory decline associated with visual hallucinations in Parkinson's disease. , 2018, Journal of neuropsychology.

[2]  M. Emre,et al.  Dementia in Parkinson's disease , 2017, Journal of the Neurological Sciences.

[3]  M. Albert,et al.  GBA Variants are associated with a distinct pattern of cognitive deficits in Parkinson's disease , 2016, Movement disorders : official journal of the Movement Disorder Society.

[4]  T. Montine,et al.  APOE, MAPT, and SNCA genes and cognitive performance in Parkinson disease. , 2014, JAMA neurology.

[5]  R. Postuma,et al.  Predictors of dementia in Parkinson disease , 2014, Neurology.

[6]  J. Marinus,et al.  Predictors of dementia in Parkinson's disease; findings from a 5-year prospective study using the SCOPA-COG. , 2014, Parkinsonism & related disorders.

[7]  T. Montine,et al.  Neuropsychologic assessment in collaborative Parkinson’s disease research: A proposal from the National Institute of Neurological Disorders and Stroke Morris K. Udall Centers of Excellence for Parkinson’s Disease Research at the University of Pennsylvania and the University of Washington , 2013, Alzheimer's & Dementia.

[8]  Paco Martorell,et al.  Monetary costs of dementia in the United States. , 2013, The New England journal of medicine.

[9]  C. Clarke,et al.  Systematic review of levodopa dose equivalency reporting in Parkinson's disease , 2010, Movement disorders : official journal of the Movement Disorder Society.

[10]  G. Stebbins,et al.  A 12-year population-based study of psychosis in Parkinson disease. , 2010, Archives of neurology.

[11]  S. Anderson,et al.  Incidence of and risk factors for cognitive impairment in an early Parkinson disease clinical trial cohort , 2009, Neurology.

[12]  Nagaendran Kandiah,et al.  Cognitive decline in early Parkinson's disease , 2009, Movement disorders : official journal of the Movement Disorder Society.

[13]  J. Jankovic,et al.  Movement Disorder Society‐sponsored revision of the Unified Parkinson's Disease Rating Scale (MDS‐UPDRS): Scale presentation and clinimetric testing results , 2008, Movement disorders : official journal of the Movement Disorder Society.

[14]  G. Halliday,et al.  The Sydney multicenter study of Parkinson's disease: The inevitability of dementia at 20 years , 2008, Movement disorders : official journal of the Movement Disorder Society.

[15]  G. Fénelon.  Psychosis in Parkinson's Disease: Phenomenology, Frequency, Risk Factors, and Current Understanding of Pathophysiologic Mechanisms , 2008, CNS Spectrums.

[16]  P. Barone,et al.  A neuropsychological longitudinal study in Parkinson's patients with and without hallucinations , 2007, Movement disorders : official journal of the Movement Disorder Society.

[17]  E. Tolosa,et al.  Clinical diagnostic criteria for dementia associated with Parkinson's disease , 2007, Movement disorders : official journal of the Movement Disorder Society.

[18]  E. Tolosa,et al.  Cognitive Changes in Parkinson’s Disease Patients with Visual Hallucinations , 2007, Dementia and Geriatric Cognitive Disorders.

[19]  D. Aarsland,et al.  A systematic review of prevalence studies of dementia in Parkinson's disease , 2005, Movement disorders : official journal of the Movement Disorder Society.

[20]  J. Cummings,et al.  The Montreal Cognitive Assessment, MoCA: A Brief Screening Tool For Mild Cognitive Impairment , 2005, Journal of the American Geriatrics Society.

[21]  Tore Wentzel-Larsen,et al.  The rate of cognitive decline in Parkinson disease. , 2004, Archives of neurology.

[22]  W. Poewe,et al.  Movement Disorder Society Task Force report on the Hoehn and Yahr staging scale: Status and recommendations The Movement Disorder Society Task Force on rating scales for Parkinson's disease , 2004, Movement disorders : official journal of the Movement Disorder Society.

[23]  K. Jellinger.  The association of incident dementia with mortality in PD , 2003, Neurology.

[24]  M. Emre.  Dementia associated with Parkinson's disease , 2003, The Lancet Neurology.

[25]  D. Aarsland,et al.  Prevalence and characteristics of dementia in Parkinson disease: an 8-year prospective study. , 2003, Archives of neurology.

[26]  K. Marder,et al.  The association of incident dementia with mortality in PD , 2002, Neurology.

[27]  J. Cummings,et al.  Validation of the NPI-Q, a brief clinical form of the Neuropsychiatric Inventory. , 2000, The Journal of neuropsychiatry and clinical neurosciences.

[28]  M. Mega,et al.  The Neuropsychiatric Inventory , 1994, Neurology.

[29]  T. Montine,et al.  Pacific Northwest Udall Center of excellence clinical consortium: study design and baseline cohort characteristics. , 2013, Journal of Parkinson's disease.

[30]  V. Leirer,et al.  Development and validation of a geriatric depression screening scale: a preliminary report. , 1982, Journal of psychiatric research.